Assess the data and tweets to estimate whether the closing price of $pfe will escalate or deflate at 2017-06-27. Respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-06-13,0.4,0.6,-0.2,-0.4,-0.4,-0.7,-0.5,-0.8,-0.8,-0.4,0.0
2017-06-14,-0.3,0.2,-0.7,0.3,0.3,-0.6,-0.8,-1.0,-1.1,-0.7,-0.4
2017-06-15,-0.6,0.7,-0.8,0.4,0.4,-0.3,-1.2,-1.2,-1.4,-1.1,-0.8
2017-06-16,0.0,0.5,-0.5,0.5,0.5,-0.7,-1.5,-1.6,-1.8,-1.6,-1.3
2017-06-19,-0.8,0.1,-0.9,0.8,0.8,-1.1,-2.0,-2.1,-2.4,-2.3,-2.0
2017-06-20,-1.0,0.6,-1.2,1.0,1.0,-1.5,-2.5,-2.8,-3.2,-3.3,-3.0
2017-06-21,-0.9,0.6,-0.9,1.0,1.0,-1.7,-2.9,-3.5,-3.8,-4.0,-3.8
2017-06-22,-0.3,1.2,-0.4,0.5,0.5,-1.5,-2.7,-3.7,-4.0,-4.3,-4.2
2017-06-23,-0.3,0.1,-0.6,0.3,0.3,-1.1,-2.7,-3.7,-4.0,-4.4,-4.4
2017-06-26,0.4,0.5,-0.2,-0.4,-0.4,-0.3,-1.9,-3.0,-3.4,-3.8,-3.9

2017-06-13: hold tight folks, i have faith that our patience will pay off  for $auph. i'm long $auph and $gild, oh and dividend faithful $pfe|dow jones analysis video - $djia $dia $sdow  $xom $ge $gs $mrk $pfe $b
2017-06-14: plenty of pharma representation in the newest installment of the fortune 500 list  $jnj $pfe $mrk $abbv $amgn $celg|06/14/17 volume leader #54 - pfe 13,819,399 pfizer inc $pfe 32.69 +0.11 +0.34% high 
2017-06-15: $ flows: selling on strength: among stocks that were up thr, these had the largest net outflows of money $ge $cmcsa¡­ |brief-u.s. fda updates on #pfizer drug shortages. read more:  $pfe|ltm ebitda mul
2017-06-16: 6 reasons why prescription drug prices are extremely expensive AT_USER #stocks $pfe, $bmrn, $bmy, $lly, $abbv |rx reading: $jnj touts positive invokana data; $rhhby, $pfe under investigation; spotligh
2017-06-17: abbvie $abbv ltm ebitda multiple trading below majority of peers: $bmy $lly $mrk $pfe $amgn  |  &lt; low cost but world class penny stock pick service my review of penny stock egghead ! $xbi $labu $pf
2017-06-18: rt AT_USER dogs of the dow underperformance gap widening $ba $cat $cvx $ibm $ko $mrk $pfe $vz $xom $csco |rx reading: jsr acquires selexis; $jnj touts positive invokana data; $rhhby, $pfe under invest
2017-06-19: rt AT_USER $pfe pfizer begins phase 1 clinical trial to evaluate investigational group b streptococcus vaccine |rt AT_USER $eled .0092, was once 75 cents. 200k shares away from 2 cents! $pfe $owcp $ch
2017-06-20: #pfizer firing on all cylinders. read more:  $pfe|#pfizer kicks off human testing with maternal gbs vaccine. read more:  $pfe|effector therapeutics to collaborates with #pfizer and merck kgaa. read mo
2017-06-21: biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn $amgn $biib $vrtx |biotechs blaze as trump draft order on drug pri... $ibb $pfe $mrk $bmy $nvs $lly $jnj $agn
2017-06-22: rt AT_USER $pfe's epo biosimilar delayed; AT_USER talked to their essential health cmo about the setback. |rt AT_USER fda rejects pfizer's marketing application for epogen biosimilar $pfe $amgn |fda r
2017-06-23: rt AT_USER concerns about the senate healthcare bill - fireworks before the 4th of july  AT_USER $aet $hca $p¡­|pfizer, inc. $pfe rating increased to sell at bidaskclub |for those struggling with $pfe
2017-06-24: rt AT_USER #watson is tackling complex #medical problems #healthcare $ibm $pfe $ilmn $mdt $dgx #ai #cognitivecomputing #bigdata |rt AT_USER #watson is tackling complex #medical problems #healthcare $i
2017-06-25: rt AT_USER $vdrm $frzt $chro $icnb $kerx $pfe $mrk $adxs $bmy $bac $c $gs $jpm $amd $dcth $csco $qqq $eled $nvax $mu $jd $ttd $an¡­|rt AT_USER $vdrm $frzt $chro $icnb $kerx $pfe $mrk $adxs $bmy $bac $
2017-06-26: rt AT_USER $vdrm $frzt $chro $icnb $kerx $pfe $mrk $adxs $bmy $bac $c $gs $jpm $amd $dcth $csco $qqq $eled $nvax $mu $jd $ttd $an¡­|how things look for opko health, inc. in 3 charts AT_USER #stocks $p
Answer:
Fall